News & Events



Corealis Pharma is continuing with its normal operations in order to support the development and manufacture of pharmaceutical products, as it is considered an “Essential Business” by the authorities.

Please rest assured that we are taking all necessary precautions and safety measures to protect our team members as we are following the sanitary protection measures promulgated by the authorities as well as restricting access to our site and re-emphasizing good hygiene practices.

We continue to operate as per our Standard Operating Procedures to ensure our unwavering commitment to the quality of our services.

Should there be any changes to our operations, we will notify and consult our partners so as to implement mitigation measures in order to re-establish our standard level of services as promptly as possible.


Corealis 2021 Expansion Underway

On Friday, December 18th, Corealis Pharma finalized the purchase of a 1.4 Acre (63,000 square foot) property that is adjacent to their current facility at 200 Armand-Frappier Boulevard in Laval.

In 2021, Corealis plans to demolish the existing structures on the property in preparation for the construction of a new facility in 2022.

Corealis continues to invest in its employees, equipment and facilities, improving the quality of their deliverables in “Formulation Development and Clinical Supply Manufacturing of Pharmaceutical Oral Solid Dosage Forms” to their pharmaceutical and biotech partners around the world.

Supporting future scientists through the Armand-Frappier Foundation

Great news!

For the 10th year in a row, Corealis Pharma is proud to support the Armand-Frappier Foundation as part of the Scotiabank Charitable Challenge!

Donations raised through this Challenge allow the Foundation to offer undergraduate internship scholarships at the Armand-Frappier Health Biotechnology Centre and thus support the next generation of scientists.

Thank you to the Armand-Frappier Foundation!

Sustaining Partnership with the AAPS

Corealis Pharma has been involved with the American Association of Pharmaceutical Scientists (AAPS) since the inception of the company, 15 years ago.

We have relied on the association for our own education and networking, as well as contributed through scientific publications, sponsorships and collaboration.

Today, we’re proud to have become a Sustaining Partner of AAPS.

We will continue our support of this important organization and hope to see you in person
(when it is safe to do so) at the next PharmSci360 (the AAPS annual meeting) in Philadelphia.